Open Actively Recruiting

Immune Profiles Associated with Development of Immune Toxicities in Checkpoint Immunotherapy-Treated Cancer Patients

About

Brief Summary

This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria.

Phase
N/A

Eligibility

Minimum Age
N/A
Maximum Age
N/A

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
20-000494
Category
Other Cancer
Contact
Melissa Lechner
Location
  • UCLA Santa Monica
  • UCLA Westwood